Left Ventricular Thrombus of Unknown Etiology in a Patient With COVID-19 Disease With No Significant Medical History

Cardiovasc Revasc Med. 2022 Jul:40S:329-331. doi: 10.1016/j.carrev.2022.03.010. Epub 2022 Mar 12.

Abstract

The incidence of left ventricular thrombus is relatively low. Ventricular thrombi typically manifest in patients with reduced ejection fraction and post myocardial infarction [1]. The impact of COVID-19's hypercoagulability state is presented here. A 44 year old male who contracted COVID-19, progressed to moderate disease requiring inpatient treatment with supplemental oxygen. During the course of the hospital stay, while receiving National Institutes of Health guideline directed thromboembolism prophylaxis for COVID-19 infected patients [2], the patient developed a left ventricular thrombus which consequently embolized and occluded the left anterior descending and left circumflex coronary arteries requiring rheolytic thrombectomy.

Keywords: Arterial thromboembolism; COVID-19; Left ventricular thrombosis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • COVID-19* / complications
  • Heart Diseases* / diagnostic imaging
  • Heart Diseases* / etiology
  • Heart Diseases* / therapy
  • Humans
  • Male
  • Myocardial Infarction*
  • Thrombectomy / adverse effects
  • Thrombosis* / diagnostic imaging
  • Thrombosis* / etiology
  • Thrombosis* / therapy